Supports advanced-stage PhD students in translational medicine research focused on innovative, clinically relevant approaches that improve disease prevention, diagnosis, or treatment.
Funder: PhRMA Foundation
Due Dates: May 27, 2026 (Letter of Intent) | November 18, 2026 (Full application, by invitation)
Funding Amounts: $30,000/year stipend for up to 2 years (12, 18, or 24 months); funds are for stipend only, not tuition or indirect costs.
Summary: Supports advanced-stage PhD students conducting translational research that bridges laboratory discoveries and clinical application, emphasizing human relevance and clinical impact.
Key Information: Full application is by invitation only after LOI review.
This fellowship supports advanced-stage predoctoral students engaged in translational medicine research aimed at improving disease prevention, diagnosis, and treatment. Funded projects must identify unmet clinical needs and propose innovative diagnostic, therapeutic, or computational approaches to enhance patient care, with a strong emphasis on human relevance and clinical validation. The program encourages research that reduces reliance on animal models, develops precision medicine strategies, and leverages computational or AI-enabled methods with clear translational potential. Proposals must articulate a therapeutically relevant hypothesis and involve clinical collaboration to ensure findings can be validated in humans or human-derived systems. Projects limited to descriptive biology or animal-only models are not eligible.